Command Palette

Search for a command to run...

Clinical Trials · NCT07319286

Role of Glucagon-like Peptide-1 Receptor Agonists in Menstrual Irregularities in Adolescent Females With Type 1 Diabetes Mellitus

Enrolling By InvitationPhase 1/Phase 2Dulaglutide (Investigational)
Phase
Phase 1/Phase 2
Recruitment status
Enrolling By Invitation
Sponsor
Ain Shams University
Enrollment
50
Start date
Aug 2025
Locations
2 sites, Egypt
Primary endpoint
Frequency of Self-Reported Menstrual Irregularities
View Dulaglutide compound reference